- Home
- IMNM vs VRE Comparison
IMNM vs VRE Comparison
Compare IMNM & VRE Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- IMNM
- VRE
- Stock Information
- Founded
- IMNM 2006
- VRE 1949
- Country
- IMNM United States
- VRE United States
- Employees
- IMNM N/A
- VRE N/A
- Industry
- IMNM Medicinal Chemicals and Botanical Products
- VRE Real Estate Investment Trusts
- Sector
- IMNM Health Care
- VRE Real Estate
- Exchange
- IMNM Nasdaq
- VRE Nasdaq
- Market Cap
- IMNM 1.2B
- VRE 1.4B
- IPO Year
- IMNM 2020
- VRE 1994
- Fundamental
- Price
- IMNM $16.39
- VRE $14.78
- Analyst Decision
- IMNM Strong Buy
- VRE Buy
- Analyst Count
- IMNM 9
- VRE 5
- Target Price
- IMNM $24.89
- VRE $19.20
- AVG Volume (30 Days)
- IMNM 1.3M
- VRE 562.4K
- Earning Date
- IMNM 11-12-2025
- VRE 10-22-2025
- Dividend Yield
- IMNM N/A
- VRE 2.15%
- EPS Growth
- IMNM N/A
- VRE N/A
- EPS
- IMNM N/A
- VRE 0.68
- Revenue
- IMNM $12,589,000.00
- VRE $291,348,000.00
- Revenue This Year
- IMNM N/A
- VRE $6.48
- Revenue Next Year
- IMNM $85.68
- VRE $1.33
- P/E Ratio
- IMNM N/A
- VRE $23.50
- Revenue Growth
- IMNM 16.74
- VRE 6.39
- 52 Week Low
- IMNM $5.15
- VRE $13.69
- 52 Week High
- IMNM $17.32
- VRE $18.85
- Technical
- Relative Strength Index (RSI)
- IMNM 65.16
- VRE 47.43
- Support Level
- IMNM $15.35
- VRE $14.52
- Resistance Level
- IMNM $17.21
- VRE $15.12
- Average True Range (ATR)
- IMNM 1.14
- VRE 0.28
- MACD
- IMNM -0.01
- VRE 0.05
- Stochastic Oscillator
- IMNM 75.79
- VRE 60.35
About IMNM Immunome Inc.
Immunome Inc is a biopharmaceutical company. It is engaged in utilizing a proprietary human memory B cell platform to discover and develop first-in-class antibody therapeutics designed to change the way diseases are currently being treated. The objective of the company is to establish a broad pipeline of preclinical and clinical assets which it can efficiently develop through successive value inflection points. The company's primary focus areas are oncology and infectious diseases, including COVID-19. It operates in the U.S. Its current pipelines comprise IM-1021, a fibroblast activation protein (FAP), and others.
About VRE Veris Residential Inc.
Veris Residential Inc is a fully-integrated, self-administered and self-managed real estate investment trust (REIT). The company owns and operates a real estate portfolio comprised predominantly of multifamily rental properties located mainly in the Northeast and Class A office properties. The company performs substantially all real estate management, leasing, acquisition and development on an in-house basis. The properties are in three states in the Northeast, plus the District of Columbia. The company operates in two industry segments multifamily real estate & services and commercial & other real estate. The majority of revenue is from Multifamily real estate services.